أفضل تشخيص شامل للأورام اللمفاوية أخصائي أمراض الدم والأورام - توب -49 أطباء

البروفيسور دراش متخصص في علم الأورام حاصل على درجة الدكتوراه من جامعة فيينا الطبية. لديه خبرة في البحث والطب الباطني وأورام الدم والتغذية ونمط الحياة في علاج السرطان. وهو مدير عيادة جوزيفستادت الخاصة في فيينا وعضو مجلس إدارة الجمعية النمساوية لأمراض الدم والأورام. نشر أكثر من 120 ورقة علمية وألقى أكثر من 200 محاضرة / عرض تقديمي.

حاصل على دبلوم طبي من كلية الطب بجامعة أولوداغ ، بورصة ، تركيا (1983) ، زمالة ما بعد الدكتوراه في العلاج الإشعاعي الحراري من جامعة توماس جيفرسون ، فيلادلفيا ، بنسلفانيا (1990-1994) ، وإقامة في علاج الأورام الإشعاعية من مركز الأورام والنووية. الطب ، اسطنبول ، تركيا (1990). كما شغل أيضًا مناصب كأستاذ ورئيس ومنسق اعتماد أعضاء هيئة التدريس في كلية الطب بجامعة أولوداغ (1991-2005) ، وأستاذ ومدير في مركز الأناضول الطبي (2004-2017) ، ومديرًا في مستشفى جيلان الدولي ومستشفى ميديكانا بورصة (2017) -الحالي).

الدكتورة شروتي كيت هي أخصائية أورام مدربة تدريباً عالياً وذات خبرة ، وهي متخصصة في علاج أنواع مختلفة من السرطان ، بما في ذلك سرطان الرئة والثدي وأمراض النساء. لقد أجرت بحثًا مكثفًا في هذا المجال ، وكانت المستفيدة الوحيدة من جائزة السفر من الهند في المؤتمر العالمي لسرطان الرئة لعام 2018.

الدكتور أحمد عارف شيخ حاصل على بكالوريوس الطب والجراحة مع 3 سنوات من الخبرة في جراحة الأورام. وهو خبير في سرطان الفم والحفاظ على الأعضاء وإعادة التأهيل الوظيفي لمرضى سرطان الفم. كما أنه بارع في إجراء جراحات الوجه والفكين الرئيسية وجراحات الرأس والرقبة ، وحصل على تدريب الزمالة في جراحة أورام الرأس والرقبة من مركز HCG Manavata للسرطان في ناشيك. وهو أيضًا باحث له العديد من المنشورات تحت اسمه.

الدكتور لاليت هو جراح أورام ذو خبرة عالية ولديه 10 سنوات من الخبرة وأكثر من 10000 عملية جراحية كبرى. لقد حصل على بكالوريوس الطب والجراحة من MIMER و Pune و MS من GMC Panaji. حصل على زمالة في جراحة الأورام وعمل محققًا رئيسيًا مشاركًا في العديد من الأبحاث الأصلية. وهو معروف بنهجه الودي والأخلاقي ، وينصب اهتمامه الرئيسي على جراحات السرطان ذات الحد الأدنى من التدخل الجراحي.

الدكتور X حاصل على بكالوريوس الطب من جامعة ميسور بالهند ودكتوراه في الطب في العلاج الإشعاعي من جامعة باناراس هندو بالهند. وهو دبلوماسي في المجلس الوطني للامتحانات وعضو في جمعية علاج الأورام بالإشعاع في الهند ، وجمعية الأورام العصبية ، ومجموعة بنغالور للأورام ، والرابطة الهندية لفرط الحرارة.

Professor Santoro is heavily involved in research, with interest in many topics, such as the development of new cancer drugs and new biological therapies, interests for solid and haematological tumours, and not only he treats cancer survivors but also patients with comorbidities.

He has worked in Humanitas Research Hospital for 22 years. Professor Santoro’s post-graduate research was carried out at the Unité de Development Therapeutique (Institut de Cancerologie et d’Immunogenetique, Villejuif of Paris) from 1974 to 1975, and in the Division of Medical Oncology of the National Cancer Institute of Milan from 1976 to 1977. 

In 1977, he specialized in Clinical and Laboratory Haematology at University of Rome. In 1979, he completed his fellowship post-graduate work in the Memorial Sloan Kettering Cancer Center of New York and later, at Stanford University. In 1980, he specialized in oncology at the University of Genoa. 

Current Teaching Activity: Professor Santoro worked as Contract Professor at the Specialization School in Clinical Pathology ad Pavia University from 1992 to 1997. Also, from 1993 to 2002 he has been President of the Rare Tumour Group. Now he is full professor at Humanitas University. 

Current Positions: 

• .Since 1997, he is the Director of the Department of Medical Oncology and Haematology, at Istituto Clinico Humanitas, Milan. Also, he is Member of the Ethics Committee of Istituto Clinico Humanitas and Director of Clinical Research in the same Institute since 2007.
• - Since 2008, he is Member of the Planning Committee, Ministry of Work and of Health and Social Politics, Rome, Italy.
• - Since October 2008, Professor Santoro is Counsellor of the Board of Directors of the Fondazione Humanitas for Research of Rozzano, Italy.
• - Since November 2008, he is Expert Member of the National Centre for the Prevention and Control of Disease, Ministry of Work and of Health and Social Politics (Rome, Italy).
• - Since February 2009, he is National Representative preparatory actions for the "European Partnership for Action against Cancer" Ministry of Work and of Health and Social Politics (Rome, Italy).
• - Since February 2009, Professor Santoro is member of National Italian Committee on the Research Network in Oncology, Ministry of Work and of Health and Social Politics (Rome, Italy).
• - Since May 2009, he is Coordinator of the Oesophageal-Stomach Cancer Group Coordinator of the Liver and Biliary Tree Cancer Group, Regional Oncology Commission – Lombardy Oncology Network.

In addition, Professor Santoro’s unique expertise was recognized through numerous awards, such as the Managing Doctor of the Year award (2013), the City of Siena S. Caterina d’Oro Award (2013, Serra Association Award for scientific research) and social and healthcare commitment (Salerno, 2009). 

Publications: santoro%a - Search Results - PubMed (nih.gov) 

Prof. Dr. Osman İLHAN graduated from Ankara University Faculty of Medicine in 1978. After completing his internal medicine residency at the same faculty in 1982, he served as a senior resident at the GATA Hematology Clinic during his military service. After completing his mandatory service at SSK Ulus Hospital, he returned to Ankara University Faculty of Medicine for a subspecialty. In 1990, he became an associate professor of hematology. He worked in Genoa, Italy to increase his knowledge and experience in leukemia. He was part of the team that performed the first bone marrow stem cell transplant in Turkey. In 1996, he went to the MD Anderson Cancer Center in the USA to work on "Stem Cell Mobilization, Cryopreservation, and Transplantation." In 1996, he became a professor of hematology. In 1999, he was elected as the regional president of ESFH (European Society for Hemapheresis). Dr. İlhan, who was the founder and president of the Hemapheresis Society in 2000, joined the World Apheresis Association (WAA) in 2001. He became the President of the Turkish Hematology Association in October 2001. Dr. İlhan, who is an active member of the European Hematology Association (EHA), was a member of the accreditation committee (ECAH) for education. He played a role in the accreditation of Turkish hematologists in CME credits by participating in the accreditation of congresses and courses held in Turkey as a Provider Status. He served as the founding president of the Cellular Therapy and Regenerative Medicine Association established in 2008. He became the founding president of the Geriatric Hematology Association in 2011. He is the Honorary President of the World Apheresis Congress (WAA) held in 2012. Dr. İlhan, who previously served on drug licensing and ethics committees at the Ministry of Health, has also served as the Chairman of the Photopheresis-Apheresis Commission and the Scientific Committee for Bone Marrow Transplantation, as well as the Chairman of the National Organ Tissue Cell Coordination Board, the Scientific Board of Cord Blood, and the Stem Cell Research Board. He is the founding president of the STEM CELL FOUNDATION and has played an important role in the establishment of TURKOK (Turkish Stem Cell Donor Bank). Dr. İlhan has over 300 publications in journals registered in PubMed and more than 5000 citations. He holds the Platinum CME certificate from the European Hematology Association. He owns four brands/patents named “Kökten Çözüm (Deep Solution), Telehematoloji (Telehematology), Hemaferez (Hemapheresis), Kanser Kök Hücresi (Cancer Stem Cell)”. He is currently the President of the Ankara Medical Association. Prof. Dr. Osman İlhan, who served at Ankara University Faculty of Medicine for 50 years, began working at Özel Koru Ankara Hospital as of January 1, 2023.

His medical interests include:

Hematopoietic Stem Cell Transplantation (Autologous, Allogeneic)

Acute Leukemia

Chronic Leukemia Treatments

Hodgkin Lymphoma

Non-Hodgkin Lymphoma Treatments

Multiple Myeloma Treatments, MDS

Aplastic Anemia

ITP

TTP Treatments

Hypercoagulability

Hereditary Thrombophilia Treatments

Therapeutic Apheresis

Photopheresis

Geriatric Hematology Diseases.

Professional Experience

Gayrettepe Florence Nigthingale Hospital

Medical Oncology Department

Besiktas/Istanbul/Turkey (ongoing)

Education:

He became Professor (22/April /2016)

Medical Oncology

Attending Phys.in Gastrointestinal Oncology (January 2005 ,2009)

Istanbul University Oncology Institue,

Department of Medical Oncology

Medical Oncology Fellowship (December 2001-December2004)

Istanbul University, Istanbul Medical Faculty

Hemodialysis Traning (May1996-January1997)

Istanbul University ,bCerrahpasa Medical Faculty

Internal Medicine Residency (November 1991-November 1996)

Istanbul University ,bCerrahpasa Medical Faculty

Ege University Medical Faculty (1985-1991)

Professional Experience

February 1999-November 2001

Metropolitan Florence Nigthingale Hospital

American Cancer Center, Gayrettepe/İstanbul

April1997- October 1998

Bayraktar Dialysis Center

Güngören/ Istanbul

Membership

Turkish Medical Oncology Association

ENET(European Neuroendocrine Tumour Society)

ESMO

ASCO